| Childhood Hygienic Practice and Family Education Status Determine the Prevalence of Helicobacter pylori Infection in Iran M Nouraie, S Latifi‐Navid, H Rezvan, AR Radmard, M Maghsudlu, ... Helicobacter 14 (1), 40-46, 2009 | 197 | 2009 |
| Risk factors predisposing to cardia gastric adenocarcinoma: Insights and new perspectives E Abdi, S Latifi‐Navid, S Zahri, A Yazdanbod, F Pourfarzi Cancer Medicine, 1–13. https ://doi.org/10.1002/c, 2019 | 95 | 2019 |
| Increase in resistance rates of H. pylori isolates to metronidazole and tetracycline-comparison of three 3-year studies F Siavashi, P Saniei, NS LATIFI, S Maserat, AA SHEYKH ARCHIVES OF IRANIAN MEDICINE 13 (3), 177-187, 2010 | 93 | 2010 |
| Green synthesis of ZnO and ZnO/CuO nanocomposites in Mentha longifolia leaf extract: characterization and their application as anti-bacterial agents R Mohammadi-Aloucheh, A Habibi-Yangjeh, A Bayrami, S Latifi-Navid, ... Journal of Materials Science: Materials in Electronics 29, 13596-13605, 2018 | 91 | 2018 |
| Ethnic and geographic differentiation of Helicobacter pylori within Iran S Latifi-Navid, SA Ghorashi, F Siavoshi, B Linz, S Massarrat, T Khegay, ... PloS one 5 (3), e9645, 2010 | 78 | 2010 |
| Helicobacter pylori infection and dietary factors act synergistically to promote gastric cancer N Raei, B Behrouz, S Zahri, S Latifi-Navid Asian Pacific Journal of Cancer Prevention 17 (3), 917-921, 2016 | 64 | 2016 |
| Helicobacter pylori vacA d1 genotype predicts risk of gastric adenocarcinoma and peptic ulcers in northwestern Iran Z Basiri, R Safaralizadeh, MJ Bonyadi, MH Somi, M Mahdavi, ... Asian Pacific Journal of Cancer Prevention 15 (4), 1575-1579, 2014 | 55 | 2014 |
| Relevance of Helicobacter pylori vacA 3ʹ‐end Region Polymorphism to Gastric Cancer SZ Bakhti, S Latifi‐Navid, S Mohammadi, S Zahri, FS Bakhti, F Feizi, ... Helicobacter 21 (4), 305-316, 2016 | 54 | 2016 |
| Enhanced anti-bacterial activities of ZnO nanoparticles and ZnO/CuO nanocomposites synthesized using Vaccinium arctostaphylos L. fruit extract R Mohammadi-Aloucheh, A Habibi-Yangjeh, A Bayrami, S Latifi-Navid, ... Artificial cells, nanomedicine, and biotechnology 46 (sup1), 1200-1209, 2018 | 52 | 2018 |
| Helicobacter pylori vacA d1/-i1 genotypes and geographic differentiation between high and low incidence areas of gastric cancer in Iran. S Latifi-Navid, S Mohammadi, P Maleki, S Zahri, A Yazdanbod, F Siavoshi, ... Archives of Iranian Medicine (AIM) 16 (6), 2013 | 51 | 2013 |
| Antioxidants with two faces toward cancer N Dastmalchi, B Baradaran, S Latifi-Navid, R Safaralizadeh, ... Life Sciences 258, 118186, 2020 | 49 | 2020 |
| Helicobacter pylori‐related risk predictors of gastric cancer: The latest models, challenges, and future prospects SZ Bakhti, S Latifi‐Navid, R Safaralizadeh Cancer medicine 9 (13), 4808-4822, 2020 | 49 | 2020 |
| Oral microbiota and Helicobacter pylori in gastric carcinogenesis: what do we know and where next? SZ Bakhti, S Latifi-Navid BMC MICROBIOLOGY 21 (1), 1-15, 2021 | 33 | 2021 |
| Entrapment of uropathogenic E. coli cells into ultra-thin sol-gel matrices on gold thin films: A low cost alternative for impedimetric bacteria sensing H Jafari, M Amiri, E Abdi, SL Navid, J Bouckaert, R Jijie, R Boukherroub, ... Biosensors and Bioelectronics 124, 161-166, 2019 | 32 | 2019 |
| Interplay and cooperation of Helicobacter pylori and gut microbiota in gastric carcinogenesis SZ Bakhti, S Latifi-Navid BMC MICROBIOLOGY 21 (10.1186/s12866-021-02315-x), 1-16, 2021 | 28 | 2021 |
| Helicobacter pylori vacA i region polymorphism but not babA2 status associated to gastric cancer risk in northwestern Iran B Mottaghi, R Safaralizadeh, M Bonyadi, S Latifi-Navid, MH Somi Clinical and experimental medicine 16, 57-63, 2016 | 28 | 2016 |
| Pneumococcal disease and the effectiveness of the PPV23 vaccine in adults: a two-stage Bayesian meta-analysis of observational and RCT reports H Latifi-Navid, S Latifi-Navid, B Mostafaiy, SA Jamalkandi, A Ahmadi Scientific reports 8 (1), 11051, 2018 | 26 | 2018 |
| FOODBORNE YEASTS SERVE AS RESERVOIRS OF HELICOBACTER PYLORI ALIH SALMANIAN, F Siavoshi, Z Beyrami, S LATIFI‐NAVID, A Tavakolian, ... Journal of Food Safety 32 (2), 152-160, 2012 | 26 | 2012 |
| Emerging circulating MiRNAs and LncRNAs in upper gastrointestinal cancers E Abdi, S Latifi-Navid, F Abdi, Z Taherian-Esfahani Expert review of molecular diagnostics 20 (11), 1121-1138, 2020 | 25 | 2020 |
| Helicobacter pylori virulence factors in relation to gastrointestinal diseases in Iran R Safaralizadeh, N Dastmalchi, MA Hosseinpourfeizi, S Latifi-Navid Microbial pathogenesis 105, 211-217, 2017 | 25 | 2017 |
Saber ZahriUniversity of mohaghegh ardabiliVerified email at uma.ac.ir
